Skip to main content

Table 2 (abstract P067). Candida albicans’ antifungal resistance

From: 38th International Symposium on Intensive Care and Emergency Medicine

  5-fluorocytosine Amphotericin B Fluconazole Itraconazole Voriconazole
Susceptible n(%) 47(92.1) 48(94.7) 46(90.2) 44(86.3) 48(94.7)
Intermediate n(%) 1(2.6) 0(0) 0(0) 0(0) 0(0)
Resistant n(%) n(%) 3(5.3) 3(5.3) 5(9.8) 7(13.7) 3(5.3)